Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Determining the Optimal Dry Powder Adenosine Provocation Test to Assess Small Airways Disease

Trial Profile

Determining the Optimal Dry Powder Adenosine Provocation Test to Assess Small Airways Disease

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 18 Sep 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Adenosine monophosphate (Primary)
  • Indications Asthma
  • Focus Diagnostic use
  • Acronyms IMPACT

Most Recent Events

  • 11 Jul 2014 Biomarkers information updated
  • 27 Jun 2013 Planned End Date changed from 1 Aug 2013 to 1 Nov 2013 as reported by ClinicalTrials.gov.
  • 28 Feb 2013 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top